Medicare Enrolled
Dr. Bachir Younes, M.D. , M.P.H.
Infectious Disease · Palm Desert, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Younes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Younes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Younes
Dr. Bachir Younes is an infectious disease specialist in Palm Desert, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Younes performed 29,251 Medicare services across 2,519 unique beneficiaries.
Between the years covered by Open Payments, Dr. Younes received a total of $8,453 from 46 pharmaceutical and/or device companies across 365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Younes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$8,453 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,251
Medicare services
Top 0% in CA for infectious disease
2,519
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,540 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
8,138 | $54 | $125 |
| Hyperbaric oxygen therapy, full body chamber Treatment involving breathing pure oxygen in a pressurized full-body chamber. The service is billed for each 30-minute interval of the procedure. |
6,423 | $146 | $250 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
2,242 | $84 | $150 |
| Oxygen chamber therapy management This code covers the professional management and oversight of a patient undergoing oxygen chamber therapy. It involves monitoring the patient's response and adjusting the treatment plan as needed. |
2,149 | $85 | $250 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
1,910 | $24 | $50 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
1,654 | $17 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,379 | $101 | $175 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
1,136 | $107 | $200 |
| Vein wound compression bandage application, lower leg, ankle, and foot Application of compression bandages to the lower leg, ankle, and foot to manage vein-related wounds. |
838 | $77 | $152 |
| Epifix, per square centimeter | 765 | $119 | $279 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
739 | $13 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
278 | $97 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
227 | $141 | $201 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
149 | $141 | $275 |
| Infusion tube insertion with imaging guidance A radiologist inserts an infusion tube into the body while using imaging guidance to ensure proper placement and reviews the procedure. |
145 | $327 | $500 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
140 | $10 | $31 |
| Negative pressure wound therapy, 50 sq cm or less A therapy using a special bandage, vacuum pump, and disposable equipment to treat a wound surface area of 50.0 square centimeters or less. |
137 | $313 | $500 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the trunk, arms, or legs covering 25 square centimeters or less. |
136 | $128 | $199 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $70 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
89 | $134 | $217 |
| New patient office visit, complex (60-74 min) | 85 | $179 | $275 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
84 | $27 | $67 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
66 | $133 | $212 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
39 | $0 | $1 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
37 | $32 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
36 | $76 | $100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $42 | $75 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
32 | $18 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $84 | $204 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
13 | $64 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.9% high complexity
2.5% medium
56.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,453
Total received (2018-2024)
Avg $1,208/year across 7 years
Top 17% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
365
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,246 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$207 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,251
2023
$1,610
2022
$1,507
2021
$509
2020
$1,198
2019
$1,414
2018
$963
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$242
Amgen Inc.
$123
Boston Scientific Corporation
$121
La Jolla Pharmaceutical Company
$108
Astellas Pharma US Inc
$76
Insmed, Inc.
$76
Merck Sharp & Dohme LLC
$73
Abbott Laboratories
$73
Paratek Pharmaceuticals, Inc.
$69
MIMEDX Group, Inc.
$53
Organogenesis Inc.
$49
Cumberland Pharmaceuticals, Inc.
$46
Shionogi Inc
$44
Theratechnologies Inc.
$35
Melinta Therapeutics, LLC
$25
Gilead Sciences, Inc.
$21
ViiV Healthcare Company
$17
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
CIPLA USA INC.
$761
Merck Sharp & Dohme Corporation
$701
Cumberland Pharmaceuticals, Inc.
$667
Janssen Biotech, Inc.
$583
Insmed, Inc.
$557
Paratek Pharmaceuticals, Inc.
$490
La Jolla Pharmaceutical Company
$445
ABBVIE INC.
$434
Merck Sharp & Dohme LLC
$418
ViiV Healthcare Company
$370
Astellas Pharma US Inc
$361
Amgen Inc.
$257
Boston Scientific Corporation
$214
Shionogi Inc
$184
Theratechnologies Inc.
$174
Intuitive Surgical, Inc.
$145
Melinta Therapeutics, Inc.
$129
TETRAPHASE PHARMACEUTICALS, INC.
$128
Nevro Corp.
$125
AbbVie Inc.
$107
Smith+Nephew, Inc.
$97
Gilead Sciences, Inc.
$97
Janssen Products, LP
$96
Takeda Pharmaceuticals U.S.A., Inc.
$90
Abbott Laboratories
$73
Melinta Therapeutics, LLC
$71
Allergan Inc.
$70
Theravance Biopharma, Inc.
$63
MIMEDX Group, Inc.
$53
Allergan, Inc.
$51
Organogenesis Inc.
$49
AMAG Pharmaceuticals, Inc.
$43
EMD Serono, Inc.
$43
Shire North American Group Inc
$42
PFIZER INC.
$39
AIMMUNE THERAPEUTICS, INC.
$38
Daiichi Sankyo Inc.
$31
Leadiant Biosciences, Inc.
$28
CSL Behring
$24
KCI USA, Inc.
$24
GRT US Holding, Inc.
$20
GlaxoSmithKline, LLC.
$14
AbbVie, Inc.
$13
Vyera Pharmaceuticals, LLC
$12
Tactile Systems Technology Inc
$12
Smith & Nephew, Inc.
$11
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · AMS 700 · APRETUDE · AVYCAZ · Abelcet · Arikayce · Baxdela · CABENUVA · CALDOLOR · CRESEMBA · CUVITRU · Cresemba · DALVANCE · DIFICID · DOVATO · Da Vinci Surgical System · Daraprim Tablet 25mg · EGRIFTA · EVENITY · Entyvio · FERAHEME · FLEXITOUCH · Fetroja · GIAPREZA · GRAFIX · Hizentra · INJECTAFER · ISENTRESS · JULUCA · KRYSTEXXA · Kimyrsa · MAVYRET · MYCAMINE · Mavyret · NOXAFIL · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Omnia · Orbactiv · PIFELTRO · PREZCOBIX · PROCLAIM · Prolia · Qutenza · Rezzayo · SEROSTIM · SYMTUZA · Santyl · Serostim · Symtuza · TEFLARO · TROGARZO · VIBATIV · VOWST · Vabomere · Vibativ · XERAVA · Xerava · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Infectious diseases within 10 mi
12
Per 100K population
0.5
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Younes is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Younes experienced with intravenous infusion, 1 hour or less?
Based on Medicare claims data, Dr. Younes performed 8,138 intravenous infusion, 1 hour or less services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Younes receive payments from pharmaceutical companies?
Yes. Dr. Younes received a total of $8,453 from 46 companies across 365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Younes's costs compare to other infectious diseases in Palm Desert?
Dr. Younes's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Younes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Palm Desert
Browse infectious diseases in Palm Desert ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in CA
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in CA
Which CA infectious diseases receive the most from drug and device companies.
By company
CIPLA USA INC. Payments to Doctors
See all physicians who received payments from CIPLA USA INC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Cumberland Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Cumberland Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology